Arrieta, F. et al. 2020. Therapeutic Approach with PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes. Cardiology and Cardiovascular Medicine. 4, 6 (Dec. 2020), 736–742.